PLUTINSKÝ, Marek, Kristián BRAT, Michal SVOBODA, Jaromir ZATLOUKAL, Patricie POPELKOVA a Vladimir KOBLIZEK. Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study. LUNG. NEW YORK: SPRINGER, 2019, roč. 197, č. 2, s. 173-179. ISSN 0341-2040. Dostupné z: https://dx.doi.org/10.1007/s00408-019-00196-6.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Prognostic Accuracy of Three COPD Classification Systems in Relation to Long-Term Mortality of COPD Patients: A Prospective Multicenter Study
Autoři PLUTINSKÝ, Marek (703 Slovensko, domácí), Kristián BRAT (703 Slovensko, garant, domácí), Michal SVOBODA (203 Česká republika, domácí), Jaromir ZATLOUKAL (203 Česká republika), Patricie POPELKOVA (203 Česká republika) a Vladimir KOBLIZEK (203 Česká republika).
Vydání LUNG, NEW YORK, SPRINGER, 2019, 0341-2040.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30203 Respiratory systems
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.817
Kód RIV RIV/00216224:14110/19:00109670
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1007/s00408-019-00196-6
UT WoS 000466205900009
Klíčová slova anglicky COPD; GOLD classification; Prognosis; Mortality
Štítky 14110215, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Soňa Böhmová, učo 232884. Změněno: 16. 5. 2019 14:44.
Anotace
Recent research showed group B patients express higher mortality compared to group C patients when GOLD A-D grouping is used. We aimed to compare the prognostic accuracy of three GOLD classification systems, I-IV (pre-2011), A-D (2011-2016) and A-D (2017-present) in relation to mortality, exacerbation risk, quality of life (QoL) assessment and specific treatments use in a real-life COPD cohort. We used the data of 720 patients from the Czech Multicenter Research Database of COPD. Four-year mortality and time-to-exacerbation using the GOLD pre-2011, 2011-2016 and 2017-present classification schemes were assessed. Moreover, distribution of specific treatments use and QoL measures were analyzed. The GOLD I-IV classification system showed gradual increase in 4-year mortality across the stages (GOLD II 18.8%, III 28.5%, IV 38.7%) (p=0.001). Using the A-D 2011-2016 classification scheme, group C patients had lower mortality (16.7%) than group B (18.7%) (p=0.009). The A-D 2017-present classification showed higher mortality in group B (25.5%) compared to group C (20%) (p=0.05). For additional outcomes, the GOLD I-IV scheme showed highest match between the calculated 4-year exacerbation risk and QoL measures and GOLD stage/grouping. In terms of specific treatment distributions, various patterns for each GOLD classification system were observed with best match of GOLD 2017-present system to the layout of GOLD groups and categories. We conclude the GOLD I-IV classification system had the highest accuracy related to mortality, QoL measures and exacerbation risk prediction, while the A-D 2017-present scheme was most accurate within severity of symptoms prediction reflected also by more frequent specific treatments use.
VytisknoutZobrazeno: 25. 4. 2024 14:31